Hologic

Hologic Inventory/Revenue

Delisted

The Inventory to Revenue Ratio of Hologic (HOLX) as of Nov 18, 2026 is 16.57 %. In the previous year, Inventory to Revenue Ratio was 16.87 % — a change of -1.77% (lower).

Inventory/Revenue

16.57 %

YoY

-1.77%

Last updated:

Inventory to Revenue Ratio of Hologic is 2025 16.57 % . Inventory to Revenue Ratio of Hologic was 2024 16.87 % . It decreases by -1.77% lower compared to the previous year.

The Hologic Inventory/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory/Revenue
Date
Inventory/Revenue
Jan 1, 2018
11.94 USD
Jan 1, 2019
13.21 USD
Jan 1, 2020
10.46 USD
Jan 1, 2021
8.90 USD
Jan 1, 2022
12.83 USD
Jan 1, 2023
15.32 USD
Jan 1, 2024
16.87 USD
Jan 1, 2025
16.57 USD
The Hologic Inventory/Revenue history
YEARInventory/RevenueYoY
16.57 %-1.77%
16.87 %+10.07%
15.32 %+19.47%
12.83 %+44.13%
8.90 %-14.95%
10.46 %-20.81%
13.21 %+10.69%
11.94 %+10.11%
10.84 %+11.79%
9.70 %-7.34%
10.47 %-19.89%
13.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hologic Stock analysis

What does Hologic do? Hologic Inc. is a company from the United States that has established itself in the medical technology market. The company was founded in 1985 by Jay A. Stein, who set the goal of developing products and services that contribute to improving people's lives. Hologic specializes in artificial intelligence (AI) based diagnostic and therapeutic technology that increases the safety, effectiveness, and accuracy of medical procedures. The company initially focused on products in the field of mammography, but has since expanded to various sectors including imaging, gynecology, skeletal, and surgery. Hologic offers its customers products such as tomosynthesis systems, robot-assisted surgery systems, image analysis software, and a variety of reagents, kits, and tests. The company's business model is focused on innovative technology and science, aiming to optimize medical interventions and thus reduce and improve healthcare costs. Hologic is dedicated to research and development and has already filed dozens of patents. In the field of breast cancer diagnostics, Hologic has developed various mammography systems that have broken the standard of mammography. Through the use of tomosynthesis, a 3D-based diagnostic, it is possible to detect tumors and malignant changes earlier. This procedure has been widely used by many doctors around the world and has proven to be a reliable method for early detection of breast cancer. In gynecology, Hologic specializes in the development of diagnostic tests for infectious agents and hormones. The tests, such as the Aptima HPV test, are fast, sensitive, and reliable. They help to detect infectious agents earlier and initiate appropriate therapy. Hologic Taurus, a robot-assisted surgery system, has been developed to enable minimally invasive interventions that can be used to treat uterine fibroids. This method allows for a drastic reduction in hospital stay duration and recovery time. In the field of skeletal, Hologic offers various systems that are helpful in the diagnosis and treatment of osteoporosis. The widely used DXA system (Dual-Energy X-Ray Absorptiometer) is still one of the most accurate devices for measuring bone density. Additionally, Hologic is an company that not only focuses on medical technology but also pursues the larger goal of improving people's lives. An example of this is their partnership with the organization Pink Ribbon, which serves as a global ambassador for breast cancer early detection. Hologic has developed a special mammography system called Pink Affirm. For every system sold, Hologic donates a certain amount to Pink Ribbon. Overall, Hologic Inc. has become an important player in the field of medical technology and diagnostics. Through its innovative technologies and products, the company contributes to improving the health and lives of people worldwide. Hologic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hologic stock

Inventory to Revenue Ratio of Hologic is 16.57 % in 2025.

Inventory to Revenue Ratio of Hologic changed from 16.87 % to 16.57 %, representing a -1.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory to Revenue Ratio Hologic since 2006 – with annual values, charts, and detailed analysis.

The Inventory/Revenue ratio shows what percentage of revenue is held as inventory. Rising ratios may indicate slowing demand or inventory management issues.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory to Revenue Ratio's Hologic with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hologic

All Key Metrics — Hologic